Hypopituitarism occurs when there is a deficiency of one or more of the pituitary hormones. In particular, growth hormone deficiency (GHD) could have a childhood onset and continue throughout adulthood or develop later in life. Adult-onset GHD is usually acquired from a pituitary tumor or trauma to the brain.
Adult GHD is characterized by nonspecific symptoms, which can make it difficult to diagnose in clinical practice. Nevertheless, these symptoms can have a significant negative impact on patients.
This independent educational program, led by a faculty comprising international key opinion leaders, aims to improve awareness of adult GHD through education on approaches to achieve an earlier diagnosis and a better management of adults with GHD.
This interactive curriculum comprises the following activities, available in English, Spanish, French, Portuguese, and Simplified Chinese:
The program is suitable for healthcare professionals worldwide, particularly endocrinologists, neurosurgeons, and primary care practitioners that might come across adults with GHD.
In this webcast, Dr Beverly MK Biller and Professor Stephen M Shalet discuss the need to increase awareness about GHD in adults, outline the classical features of patients with this condition, and summarize the strategies that can help identify adults who may have GHD.
Subtitles available in English, Spanish, French, Portuguese, and Simplified Chinese.
JUST LAUNCHED! Interactive case studies designed to improve your knowledge of adult GHD and to guide you in the management of GHD patients in your clinical practice.
Subtitles available: English, Spanish, French, Portuguese, and Simplified Chinese
After participating in the program, learners will be able to:
Professor of Medicine at Harvard Medical School (HMS), USA
Faculty member in the Neuroendocrine & Pituitary Tumor Clinical Center at Massachusetts General Hospital (MGH) in Boston, Massachusetts, USA
Dr. Biller is Program Director of the Clinical Fellowship in Adult Endocrinology and Metabolism at MGH. She also directs the annual HMS & MGH Continuing Medical Education course “Clinical Endocrinology” that welcomes endocrinologists from around the world to Boston every Spring.
Major research interests include the diagnosis and treatment of Cushing’s disease, acromegaly, prolactinomas, and growth hormone deficiency (GHD) in adults. Dr. Biller has published original research in many peer-reviewed journals and has co-authored clinical guidelines regarding Cushing’s disease for the Endocrine and Pituitary Societies, on pituitary adenomas in pregnancy for the European Society of Endocrinology and on adult GHD for the American Association of Clinical Endocrinologists.
Dr. Biller discloses a grant received from Ascendis, consulting/Honoraria from Merck Serono and consulting honoraria from Novo Nordisk.
All relevant financial relationships have been mitigated.
In support of improving patient care, this activity has been planned and implemented by Springer Healthcare IME and HMP Education. HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
HMP Education designates AMA PRA Category Credit(s)™ for the following activities:
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In addition to the speaker faculty, HMP Education and Springer Healthcare IME planners and staff include Randy Robin, Rachel Goddard & Alba Ruzafa.
Randy Robbin, Rachel Goddard and Alba Ruzafa have no financial relationships to disclose.
This program is made possible thanks to an independent educational grant from Novo Nordisk Health Care AG. Novo Nordisk Health Care AG has had no influence over the content of this program.
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK